These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 6227281

  • 1. Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid, and nalidixic acid.
    Muytjens HL, van der Ros-van de Repe J, van Veldhuizen G.
    Antimicrob Agents Chemother; 1983 Aug; 24(2):302-4. PubMed ID: 6227281
    [Abstract] [Full Text] [Related]

  • 2. In vitro activities of ciprofloxacin, norfloxacin, pipemidic acid, cinoxacin, and nalidixic acid against Chlamydia trachomatis.
    Heessen FW, Muytjens HL.
    Antimicrob Agents Chemother; 1984 Jan; 25(1):123-4. PubMed ID: 6230988
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. In vitro activity of norfloxacin in synthetic media and human urine compared to that of cinnoxacin, nalidixic acid and pipemidic acid.
    Shah PM, Ottnad-Walz M, Stille W.
    Methods Find Exp Clin Pharmacol; 1983 Dec; 5(10):731-4. PubMed ID: 6231438
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid.
    Barry AL, Jones RN, Thornsberry C, Ayers LW, Gerlach EH, Sommers HM.
    Antimicrob Agents Chemother; 1984 May; 25(5):633-7. PubMed ID: 6233935
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid.
    Bauernfeind A, Petermüller C.
    Eur J Clin Microbiol; 1983 Apr; 2(2):111-5. PubMed ID: 6222896
    [Abstract] [Full Text] [Related]

  • 9. Incomplete cross-resistance of nalidixic and pipemidic acid-resistant variants of Serratia marcescens against ciprofloxacin, enoxacin, and norfloxacin.
    Traub WH.
    Chemotherapy; 1985 Apr; 31(1):34-9. PubMed ID: 3156026
    [Abstract] [Full Text] [Related]

  • 10. [In vitro activity of seven gyrase inhibitors of a group of heterocyclic carbonic acids against nonfermenting gram negative rods (nonfermenters)].
    Grimm H.
    Arzneimittelforschung; 1985 Apr; 35(3):570-2. PubMed ID: 2986655
    [Abstract] [Full Text] [Related]

  • 11. [Antibacterial in-vitro activity of pipemidic acid and nalidixic acid (author's transl)].
    Peters G, Freiesleben H, Marre R, Metz H, Tannenberg H, Pulverer G.
    Dtsch Med Wochenschr; 1979 Jun 29; 104(26):946-8. PubMed ID: 110574
    [Abstract] [Full Text] [Related]

  • 12. The in-vitro activity of ciprofloxacin compared with that of norfloxacin and nalidixic acid.
    King A, Shannon K, Phillips I.
    J Antimicrob Chemother; 1984 Apr 29; 13(4):325-31. PubMed ID: 6233249
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparative in vitro activity of five quinoline derivatives and five other antimicrobial agents used in oral therapy.
    Hoogkamp-Korstanje JA.
    Eur J Clin Microbiol; 1984 Aug 29; 3(4):333-8. PubMed ID: 6237901
    [Abstract] [Full Text] [Related]

  • 15. In vitro and in vivo antibacterial activity of AT-2266.
    Kouno K, Inoue M, Mitsuhashi S.
    Antimicrob Agents Chemother; 1983 Jul 29; 24(1):78-84. PubMed ID: 6226242
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the antibacterial in vitro and in vivo activity of ofloxacin (HOE 280 DL 8280) and nalidixic acid analogues.
    Seibert G, Limbert M, Klesel N.
    Eur J Clin Microbiol; 1983 Dec 29; 2(6):548-53. PubMed ID: 6230226
    [Abstract] [Full Text] [Related]

  • 17. The comparative in-vitro activity of norfloxacin, ciprofloxacin, enoxacin and nalidixic acid against 423 strains of gram-negative rods and staphylococci isolated from infected hospitalised patients.
    Guimaraes MA, Noone P.
    J Antimicrob Chemother; 1986 Jan 29; 17(1):63-7. PubMed ID: 2936708
    [Abstract] [Full Text] [Related]

  • 18. Cross resistance of quinolone derivatives in gram-negative bacteria.
    Barba D, Pennucci C, Esposito S, Galante D.
    Chemioterapia; 1985 Apr 29; 4(2):192-6. PubMed ID: 3159488
    [Abstract] [Full Text] [Related]

  • 19. The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
    King A, Phillips I.
    J Antimicrob Chemother; 1986 Nov 29; 18 Suppl D():1-20. PubMed ID: 3468100
    [Abstract] [Full Text] [Related]

  • 20. Comparative in vitro activity of ciprofloxacin and five other quinoline derivatives against gram-negative isolates.
    Galante D, Pennucci C, Esposito S, Barba D.
    Drugs Exp Clin Res; 1985 Nov 29; 11(5):331-4. PubMed ID: 2941260
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.